Journal
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY
Volume 5, Issue 5, Pages 505-510Publisher
AMER SCIENTIFIC PUBLISHERS
DOI: 10.1166/jbn.2009.1070
Keywords
Magnetic Nanoparticles; Antibody; Alkaline Phosphatase; Chemiluminescence; Escherichia coli O157:H7
Ask authors/readers for more resources
This paper described that Fe3O4 nanoparticles were encapsulated with methyl methacrylate (MMA) using linolenic acid (LA) as a crosslinking agent, after which the resulting polymethyl methacrylate (PMMA) embed Fe3O4 nanoparticles (PMMA/Fe3O4) were coated with silica, forming SiO2/ (PMMA/Fe3O4) core-shell structure particles. Then these magnetic nanoparticles (MNPs) were applied in the developed system of chemiluminescent magnetic enzyme-linked immunoassay. E coli O157:H7 was sandwiched between rabbits anti-E. coli O157:H7 polyclonal antibody-coated magnetite nanoparticles (immunomagnetic nanoparticles or IMNPs) and mouse anti-E. coli O157:H7 monoclonal antibody (E. coli O157-McAb). Commercial alkaline phosphatase conjugated horse M anti-mouse immunoglobulin (ALP-Ab) was used to bond with the monoclonal antibody, finally U) M the chemiluminescent signals were detected by adding 3-(2'-spiroadamantane)-4-methoxy-4-(3- phosphoryloxy)phenyl-1,2-dioxetane (AMPPD) which was the substrate reagent of ALP. The specificity and sensitivity of this system for detecting E. coli O157:H7 were researched. The results indicated that this method was of good specificity when using E. coli Top 10F' and Vibrio cholera as negative controls. The detection limit was 10(3) cells mL(-1) when the antigen solution was 1 mL, and the procedure duration was about 3 h.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available